Tıp Fakültesi / Faculty of Medicine
Permanent URI for this collectionhttps://hdl.handle.net/11727/1403
Browse
2 results
Search Results
Item Can We Use Red Cell Distribution as A Marker of Mortality in Acute Myocardial Infarcts?(2015) Yilmaz, Muhittin Serkan; Isik, Bahattin; Kavalci, Cemil; Salt, Omer; Yel, Cihat; Demirci, Burak; Yilmaz, Fevzi; Durdu, Tamer; Ongar, Murat; Ozdemir, Metin; 0000-0003-2529-2946; AGG-1308-2022Introduction: Red cell distribution width (RDW) is elevated in ischemic diseases and it is reported that this elevation is associated with mortality in this process. In this study, it is aimed to investigate the place of Red cell distribution width in the diagnosis of myocardial infarction and short-term effect on mortality in the patients presenting with chest pain. Materials and methods: The study was performed retrospectively between 1 July 2013 - 31 December 2013. Age, gender, Red cell distribution width, the affected cardiac region, and cardiac mortality levels of the patients with chest pain who were included in the study were examined. In the descriptive statistics of data; mean, standard deviation, and frequency ratio values were used. In the analysis of quantitative data, Mann-Whitney U test was used. Results were evaluated at 95% confidence interval, significance were evaluated at p <0.05. Results: The median age of patients with Acute myocardial infarction was 69 (Range = 65) and 230 of whom (68.9%) were male) in the study. Red Cell Distribution Width was significantly higher in the group with diagnosis of Acute myocardial infarction (p <0.05). The most frequently seen myocardial infarctus type was anterior myocardial infarction (23.8%) whereas hypertension has been found to be accompanied. Red Cell Distribution Width was significantly higher in the patients who died with a diagnosis of Acute myocardial infarction. Conclusion: As a result, the Red cell distribution width level, can be considered as statistically significant in patients with Acute myocardial infarction and is a parameter that may be associated with mortality.Item Bedside Heart Type Fatty Acid Binding Protein (H-FABP): Is an Early Predictive Marker of Cardiac Syncope(2015) Sonmez, Bedriye Muge; Ozturk, Derya; Yilmaz, Fevzi; Altinbilek, Ertugrul; Kavalci, Cemil; Durdu, Tamer; Hakbilir, Oktay; Turhan, Turan; Ongar, Murat; 0000-0003-2529-2946; 26564283; AGG-1308-2022Objective: To determine the value of bedside heart-type fatty acid binding protein in diagnosis of cardiac syncope in patients presenting with syncope or presyncope. Methods: The prospective study was conducted at Ankara Numune Training and Research Hospital, Ankara, Turkey, between September 1, 2010, and January 1, 2011, and comprised patients aged over 18 years who presented with syncope or presyncope. Patients presenting to emergency department within 4 hours of syncope or presyncope underwent a bedside heart-type fatty acid binding protein test measurement. SPSS 16 was used for statistical analysis, Results: Of the 100 patients evaluated, 22(22%) were diagnosed with cardiac syncope. Of them, 13(59.1%) patients had a positive and 9(40.9%) had a negative heart-type fatty acid binding protein result. Consequently, the test result was 12.64 times more positive in patients with cardiac syncope compared to those without. Conclusions: Bedside heart-type fatty acid binding protein, particularly at early phase of myocardial injury, reduces diagnostic and therapeutic uncertainity of cardiac origin in syncope patients.